The DE@ ( methotrexate -LSB- MTX -RSB- - inadequate responders , longstanding RA ) and PREMIER ( MTX-naive , early RA ) studies , respectively , had @ - or @-year double-blind periods followed by @ - or @-year open-label extensions ( OLEs ) .